DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection

Vaccine

Volumn 17, Issue 3, 1999, Pages 237-244

  Ruitenberg, K M ^a   Walker, C ^a   Wellington, J E ^a   Love, D N ^b   Whalley, J M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

DNA immunization; Equine herpesvirus 1; Glycoprotein D; Mouse model

Indexed keywords

DNA VACCINE; NEUTRALIZING ANTIBODY; PLASMID DNA; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; EQUINE HERPES VIRUS; FEMALE; HELPER CELL; HUMORAL IMMUNITY; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VACCINATION;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; DISEASE MODELS, ANIMAL; DNA; FEMALE; GENETIC CODE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; PLASMIDS; RESPIRATORY TRACT INFECTIONS; VIRAL ENVELOPE PROTEINS;

EID: 0345367428     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00192-3     Document Type: Article

References (38)

1. Allen GP, Bryans JT. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. In: Pandey R, editor. Progress veterinary microbiology and immunology, vol 2. Basel: S. Karger, 1986. p. 78-144.
2. Crabb B.S., Studdert M.J. Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv Virus Res. 45:1995;153-190.
3. Davis-Poynter N.J., Farrell H.E. Masters of deception: a review of herpesvirus immune evasion strategies [review]. Immunol Cell Biol. 74:1996;513-522.
4. Gilkerson J.R., Love D.N., Whalley J.M. A review of equine herpesvirus vaccines: from the traditional to the experimental. Aust Equine Vet. 15:1997;27-32.
5. Burki F., Rossmanith W., Nowotny N., Pallan C., Mostl K.et al. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet Q. 12:1990;80-86.
6. Awan A.R., Chong Y.C., Field H.J. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J Gen Virol. 71:1990;1131-1140.
7. Awan A.R., Gibson J.S., Field H.J. A murine model for studying EHV-1-induced abortion. Res Vet Sci. 51:1991;94-99.
8. Csellner H., Whalley J.M., Love D.N. Equine herpesvirus-1 HVS 25A isolated from an aborted foetus produces disease in BALB/c mice. Aust Vet J. 72:1995;68-69.
9. Alber D.G., Greensill J., Killington R.A., Stokes A. Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2(K)) and BALB/c (H-2(D)) mice. Res Vet Sci. 59:1995;205-213.
10. Tewari D., Whalley J.M., Love D.N., Field H.J. Characterization of immune responses to baculovirus expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J Gen Virol. 75:1994;1735-1741.
11. Tewari D., Nair S.V., De Ungria M.C., Lawrence G.L., Hayden M.et al. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Arch Virol. 140:1995;789-797.
12. Stokes A., Cameron R.S., Marshall R.N., Killington R.A. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3h (h-2k(k)) murine model. Virus Res. 50:1997;159-173.
13. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L.et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
14. Wolff J.A., Malone R.W., Williams P., Chong Y., Acsadi G.et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
15. Robinson H.L. Nucleic acid vaccines: an overview. Vaccine. 15:1997;785-787.
16. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines [review]. Annu Rev Immunol. 15:1997;617-648.
17. Osterrieder N., Wagner R., Brandmuller C., Schmidt P., Wolf H.et al. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology. 208:1995;500-510.
18. Whalley J.M., Robertson G.R., Davison A.J. Analysis of the genome of equine herpesvirus type 1: arrangement of cleavage sites for restriction endonucleases EcoRI, BglII and BamHI. J Gen Virol. 57:1981;307-323.
19. Wellington J.E., Lawrence G.L., Love D.N., Whalley J.M. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch Virol. 141:1996;1785-1793.
20. Love D.N., Bell C.W., Whalley J.M. Characterization of the glycoprotein-D gene products of equine herpesvirus-1 using a prokaryotic cell expression vector. Vet Microbiol. 30:1992;387-394.
21. Wellington J.E., Gooley A.A., Love D.N., Whalley J.M. N-terminal sequence analysis of equine herpesvirus 1 glycoproteins D and B and evidence for internal cleavage of the gene 71 product. J Gen Virol. 77:1996;75-82.
22. Love D.N., Bell C.W., Pye D., Edwards S., Hayden M.et al. Expression of equine herpesvirus-1 glycoprotein-D by using a recombinant baculovirus. J Virol. 67:1993;6820-6823.
23. Danko I., Fritz J.D., Jiao S.S., Hogan K., Latendresse J.S.et al. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1:1994;114-121.
24. Deck R.R., DeWitt C.M., Donnelly J.J., Liu M.A., Ulmer J.B. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine. 15:1997;71-78.
25. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA. 93:1996;11414-11420.
26. Kriesel J.D., Spruance S.L., Daynes R.A., Araneo B.A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J Infect Dis. 173:1996;536-541.
27. Ghiasi H., Cai S., Slanina S., Nesburn A.B., Wechsler S.L. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28:1995;147-157.
28. Cox G.J.M., Zamb T.J., Babiuk L.A. Bovine herpesvirus-1: immune responses in mice and cattle injected with plasmid DNA. J Virol. 67:1993;5664-5667.
29. Manickan E., Yu Z.Y., Rouse R.J.D., Wire W.S., Rouse B.T. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27. Viral Immunol. 8:1995;53-61.
30. Kukreja A, Love DN, Whalley JM, Field HJ. Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus 1 in a murine intranasal infection model. Vet Microbiol 1998;60:1-11.
31. Manickan E., Rouse R.J.D., Yu Z.Y., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus: protection is mediated by CD4(+) T lymphocytes. J Immunol. 155:1995;259-265.
32. Bourne N., Milligan G.N., Schleiss M.R., Bernstein D.I., Stanberry L.R. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine. 14:1996;1230-1234.
33. Barry M.A., Johnston S.A. Biological features of genetic immunization. Vaccine. 15:1997;788-791.
34. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol. 158:1997;2278-2284.
35. Lewis P.J., Cox G.J.M., van Drunen Littel-van den Hurk S., Babiuk L.A. Polynucleotide vaccines in animals: enhancing and modulating responses. Vaccine. 15:1997;861-864.
36. Whalley M., Robertson G., Bell C., Love D., Elphinstone M.et al. Identification and comparative sequence analysis of a gene in equine herpesvirus-1 with homology to the herpes simplex virus glycoprotein-D gene. Virus Genes. 5:1991;313-325.
37. Ramsay A.J., Leong K.H., Ramshaw I.A. DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunol Cell Biol. 75:1997;382-388.
38. Okuda K., Xin K.Q., Tsuji T., Bukawa H., Tanaka S.et al. DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity. Vaccine. 15:1997;1049-1056.